JP Morgan Chase’s Marrone Bio Innovations, Inc. MBII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-332
| Closed | – | – | 7179 |
|
|
2022
Q2 | $0 | Sell |
332
-47,487
| -99% | -$49.6K | ﹤0.01% | 7170 |
|
|
2022
Q1 | $51K | Sell |
47,819
-96,434
| -67% | -$72.8K | ﹤0.01% | 5794 |
|
|
2021
Q4 | $104K | Buy |
144,253
+81,766
| +131% | +$66.1K | ﹤0.01% | 5666 |
|
|
2021
Q3 | $56K | Buy |
62,487
+23,690
| +61% | +$28.5K | ﹤0.01% | 5806 |
|
|
2021
Q2 | $65K | Sell |
38,797
-138,146
| -78% | -$231K | ﹤0.01% | 5666 |
|
|
2021
Q1 | $369K | Buy |
176,943
+1,669
| +1% | +$3.47K | ﹤0.01% | 4861 |
|
|
2020
Q4 | $219K | Buy |
175,274
+120,602
| +221% | +$144K | ﹤0.01% | 4781 |
|
|
2020
Q3 | $69K | Sell |
54,672
-698
| -1% | -$849 | ﹤0.01% | 4844 |
|
|
2020
Q2 | $64K | Sell |
55,370
-29,607
| -35% | -$27.4K | ﹤0.01% | 4742 |
|
|
2020
Q1 | $70K | Buy |
84,977
+17,108
| +25% | +$18.1K | ﹤0.01% | 4627 |
|
|
2019
Q4 | $68K | Buy |
67,869
+50,859
| +299% | +$61.7K | ﹤0.01% | 5029 |
|
|
2019
Q3 | $24K | Buy |
17,010
+2,759
| +19% | +$3.9K | ﹤0.01% | 5371 |
|
|
2019
Q2 | $21K | Buy |
14,251
+942
| +7% | +$1.46K | ﹤0.01% | 5434 |
|
|
2019
Q1 | $20K | Sell |
13,309
-625
| -4% | -$954 | ﹤0.01% | 5413 |
|
|
2018
Q4 | $20K | Buy |
13,934
+1,298
| +10% | +$1.99K | ﹤0.01% | 5332 |
|
|
2018
Q3 | $23K | Buy |
12,636
+1,558
| +14% | +$3.02K | ﹤0.01% | 5397 |
|
|
2018
Q2 | $20K | Buy |
+11,078
| New | +$20.6K | ﹤0.01% | 5307 |
|
|
2016
Q1 | – | Sell |
-629
| Closed | -$1K | – | 5037 |
|
|
2015
Q4 | $1K | Buy |
+629
| New | +$1.35K | ﹤0.01% | 4636 |
|
JP Morgan Chase's MBII Position: Q3 2022 in Review
JP Morgan Chase sold out of Marrone Bio Innovations, Inc. (MBII) in Q3 2022, closing a stake of 332 shares.
JP Morgan Chase first reported a position in MBII in Q4 2015 and held it in 18 quarters. The position peaked at $369K in Q1 2021. 0 funds tracked by Wall St. Rank hold MBII as of Q3 2022.
- JP Morgan Chase reported no remaining Marrone Bio Innovations, Inc. position as of Q3 2022 after selling out during the quarter.
- JP Morgan Chase sold 332 Marrone Bio Innovations, Inc. shares in Q3 2022.
- JP Morgan Chase first reported a position in Marrone Bio Innovations, Inc. in Q4 2015 and held it in 18 quarters.
- JP Morgan Chase's Marrone Bio Innovations, Inc. position peaked at $369K in Q1 2021.
- 0 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2022.
Based on JP Morgan Chase's 13F filing for Q3 2022, filed 14 Nov 2022.